The LINC01016/miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis highlighted a novel class of lncRNA–miRNA interactions, which may guide future treatments in endometrial cancer. This evidence concerns the gene SATB1 and endometrial cancer.